Browsing Tag

AVT02

Alvotech and Bioventure Announce Approval of AVT02 (adalimumab) as Simlandi in Saudi Arabia

Jason Junior Jan 24, 2023

AVT02 as Simlandi™ is the first biosimilar approved under the strategic partnership between Alvotech and Bioventure Alvotech (NASDAQ: ALVO) and Bioventure, a wholly owned subsidiary of GlobalOne Healthcare Holding LLC (“GHH”), the…

Health

Alvotech og Bioventure fá markaðsleyfi fyrir AVT02 (adalimumab) í Sádi-Arabíu

Jason Junior Jan 24, 2023

Alvotech (NASDAQ: ALVO) og Bioventure, dótturfyrirtæki GlobalOne Healthcare Holding LLC, heilbrigðissviðs YAS Holding LLC, tilkynntu í dag að lyfja- og matvælaeftirlit Sádi-Arabíu (SFDA) hafi veitt leyfi til framleiðslu og sölu á AVT02,…